Studies Evaluating Effectiveness of Risk Minimisation Measures

被引：0
|
作者：
Francisca, R. D. C. [1 ]
Zomerdijk, I. M. [1 ]
Sturkenboom, M. C. J. M. [1 ]
Straus, S. M. J. M. [1 ]
机构：
[1] Erasmus MC, Med Informat, Rotterdam, Netherlands
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2016年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
713
引用
收藏
页码：416 / 416
页数：1
相关论文
共 50 条
  • [21] A methodology for evaluating effectiveness of risk control measures for ships
    Kaneko, F
    Endo, H
    Ishida, S
    Ota, S
    Yamao, T
    Fukumoto, M
    Dai, XX
    Ikemoto, Y
    CONTROL APPLICATIONS IN MARINE SYSTEMS (CAMS'98), 1999, : 303 - 308
  • [22] Sampling Frame Stratification is Crucial in Evaluating the Effectiveness of Additional Risk Minimisation Activities (ARMAs)
    Banerjee, A. K.
    Ingate, S.
    Mayall, S. J.
    Boyall, P.
    Wells, S.
    Wooder, S.
    DRUG SAFETY, 2014, 37 (10) : 845 - 846
  • [23] Effectiveness of risk minimisation measures for valproate: A cross-sectional survey among physicians in Europe
    Toussi, Massoud
    Isabelle, Bardoulat
    Tcherny-Lessenot, Stephanie
    de Voogd, Hanka
    Dimos, Vasilis
    Kaplan, Sigal
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 (03) : 283 - 291
  • [24] Risk minimisation measures for fentanyl buccal tablets
    Reactions Weekly, 2019, 1779 (1) : 11 - 11
  • [25] Risk-minimisation measures implemented for dosulepin
    Reactions Weekly, 2007, 1182 (1) : 2 - 2
  • [26] The limitations of some European healthcare databases for monitoring the effectiveness of pregnancy prevention programmes as risk minimisation measures
    Charlton, R. A.
    Bettoli, V.
    Bos, H. J.
    Engeland, A.
    Garne, E.
    Gini, R.
    Hansen, A. V.
    de Jong-van den Berg, L. T. W.
    Jordan, S.
    Klungsoyr, K.
    Neville, A. J.
    Pierini, A.
    Puccini, A.
    Sinclair, M.
    Thayer, D.
    Dolk, H.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (04) : 513 - 520
  • [27] The limitations of some European healthcare databases for monitoring the effectiveness of pregnancy prevention programmes as risk minimisation measures
    R. A. Charlton
    V. Bettoli
    H. J. Bos
    A. Engeland
    E. Garne
    R. Gini
    A. V. Hansen
    L. T. W. de Jong-van den berg
    S. Jordan
    K. Klungsøyr
    A. J. Neville
    A. Pierini
    A. Puccini
    M. Sinclair
    D. Thayer
    H. Dolk
    European Journal of Clinical Pharmacology, 2018, 74 : 513 - 520
  • [28] Effectiveness of risk minimisation measures for valproate: a drug utilisation study in Europe, analysis of data from Spain
    Ehlken, Birgit
    Stevanovic, Irena
    Kaplan, Sigal
    Dresco, Isabelle
    Granados, Denis
    Toussi, Massoud
    REVISTA DE NEUROLOGIA, 2021, 73 (11) : 373 - 382
  • [29] A Review of Cross-Sectional Survey Studies Evaluating Risk Minimisation Measures in European Union (EU) Using the EU Electronic Register of Post-Authorisation Studies
    Vora, Pareen
    Artime, Esther
    Soriano-Gabarro, Montse
    Qizilbash, Nawab
    Asiimwe, Alex
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 11 - 11
  • [30] Additional risk minimisation measures for medicines approved in the EU
    Reactions Weekly, 2020, 1826 (1) : 6 - 6
12345